Cover Image

SGLT2 Inhibitors Decrease Overhydration and Proteasuria in Patients with Chronic Kidney Disease: A Longitudinal Observational Study

Introduction: SGLT2 inhibitors are used to reduce the risk of progression of chronic kidney disease (CKD). In patients with type 2 diabetes, they have been found to reduce extracellular volume. Given the high prevalence of extracellular volume expansion and overhydration (OH) in CKD, we investigated...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anja Schork (Author), Marie-Luise Eberbach (Author), Bernhard N. Bohnert (Author), Matthias Wörn (Author), David J. Heister (Author), Felix Eisinger (Author), Elisabeth Vogel (Author), Nils Heyne (Author), Andreas L. Birkenfeld (Author), Ferruh Artunc (Author)
Format:	Book
Published:	Karger Publishers, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Overhydration Measured by Bioimpedance Spectroscopy and Urinary Serine Protease Activity Are Risk Factors for Progression of Chronic Kidney Disease
by: Anja Schork, et al.
Published: (2020)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
by: Moritz Mahling, et al.
Published: (2019)

Impact of Phosphorus Restriction and Vitamin D-Substitution on Secondary Hyperparathyroidism in a Proteinuric Mouse Model
by: Bernhard N. Bohnert, et al.
Published: (2015)

Elimination of Contrast Agent Gadobutrol with Sustained Low Efficiency Daily Dialysis Compared to Intermittent Hemodialysis
by: Hanno Bunz, et al.
Published: (2019)

Treatment of extreme overhydration in an adolescent boy with idiopathic nephrotic syndrome
by: Andrzej Szydłowski, et al.
Published: (2022)

Mortality Prediction Using Modern Peptide Biomarkers in Hemodialysis Patients - A Comparative Analysis
by: Ferruh Artunc, et al.
Published: (2014)

The association of Overhydration Status with Depression and Health-related Quality of Life in Peritoneal Dialysis Patients
by: Hye Eun Yoon, et al.
Published: (2014)

Overhydration measured by bioimpedance analysis and the survival of patients on maintenance hemodialysis: a single-center study
by: Ye Jin Kim, et al.
Published: (2015)

Routine Monitoring of Sodium and Phosphorus Removal in Peritoneal Dialysis (PD) Patients Treated with Continuous Ambulatory PD (CAPD), Automated PD (APD) or Combined CAPD+APD
by: Veronika Moor, et al.
Published: (2017)

Widespread Calcifications Delineating an Arterial Vessel Tree in a Peritoneal Dialysis Patient
by: Ferruh Artunç, et al.
Published: (2022)

Independent Association of Overhydration with All-Cause and Cardiovascular Mortality Adjusted for Global Left Ventricular Longitudinal Systolic Strain and E/E' Ratio in Maintenance Hemodialysis Patients
by: Jiun-Chi Huang, et al.
Published: (2018)

Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches
by: Yu Zhang, et al.
Published: (2023)

Implementation of Urgent Start Peritoneal Dialysis Reduces Hemodialysis Catheter Use and Hospital Stay in Patients with Unplanned Dialysis Start
by: Ferruh Artunc, et al.
Published: (2019)

Eryptosis - the Neglected Cause of Anemia in End Stage Renal Disease
by: Florian Lang, et al.
Published: (2017)

Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
by: Zofia Wicik, et al.
Published: (2022)

Reduced Erythrocyte Survival in Uremic Patients Under Hemodialysis or Peritoneal Dialysis
by: Rosi Bissinger, et al.
Published: (2016)

The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review
by: Aurélie Pahud de Mortanges, et al.
Published: (2021)

Essential role of DNA-PKcs and plasminogen for the development of doxorubicin-induced glomerular injury in mice
by: Bernhard N. Bohnert, et al.
Published: (2021)

Use systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans
by: Yasong eLu, et al.
Published: (2014)

The use of SGLT2 inhibitors in the treatment of cognitive disorders
by: Marta Lato, et al.
Published: (2023)

SGLT-2 inhibitors: Post infarction interventional effects
by: Pugazhenthan Thangaraju, et al.
Published: (2023)

SGLT2 inhibitors and the changing landscape for treatment of diabetes
by: Liu S, et al.
Published: (2019)

SGLT2 inhibitors: control of glycemia and nephroprotection properties
by: A. A. Volodin, et al.
Published: (2018)

SGLT2 inhibitors: suggestions from the amphibian world
by: Stefano Michelassi
Published: (2022)

SGLT2 Inhibitors and Fracture Risk in Elderly Population
by: Vishal R Tandon, et al.
Published: (2023)

CONTINUED OPTIMIZATION OF USE OF SGLT-2I FOR HF: IMPROVING PRESCRIPTION REFILLS OF SGLT2I AT UT TYLER INTERNAL MEDICINE RESIDENT CLINIC
by: Mariam Qazi, DO
Published: (2024)

SGLT2-Inhibitors - significant role in Heart Failure treatment
by: Karol Wielgus, et al.
Published: (2024)

Emerging data on SGLT2 benefits in acute coronary syndromes
by: Aidin Rawshani
Published: (2024)

Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
by: Kai-Fan Tsai, et al.
Published: (2021)

Reply to SGLT-2 inhibitors: Post-infarction interventional effects
by: Pasquale Paolisso, et al.
Published: (2023)

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
by: Maria Elena Lunati, et al.
Published: (2022)

SGLT1: A Potential Drug Target for Cardiovascular Disease
by: Zhao M, et al.
Published: (2023)

Bibliometric and visual analysis of SGLT2 inhibitors in cardiovascular diseases
by: Runfang Pan, et al.
Published: (2024)

SGLT-2 inhibitors in the management of acute decompensated heart failure
by: Anastasia E. Poskakalova, et al.
Published: (2024)

Psoriasiform lesions as a side effect of SGLT-2 therapy
by: Jakub Krzysztof Gałązka, et al.
Published: (2023)

Determination of Procalcitonin Levels in Patients with Nephropathia Epidemica - A Useful Tool or an Unnecessary Diagnostic Procedure?
by: Joerg Latus, et al.
Published: (2015)

Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
by: Lea El Hage MD, et al.
Published: (2019)

SGLT-2 inhibitors: new effective drugs for treatment of heart failure
by: Olgierd Król, et al.
Published: (2022)

The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
by: Klaudia Kowalska, et al.
Published: (2022)

Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential
by: Min Sun, et al.
Published: (2024)